Status:
UNKNOWN
Effect of tDCS in Intrinsic Functional Brain Connectivity Assessed by Functional Magnetic Resonance in Fibromyalgia
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Fibromyalgia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Considering the central component of fibromyalgia (FM), the focus of research on current therapeutic approaches has been techniques that may modify the dysfunctional neuroplasticity process, such as t...
Detailed Description
Fibromyalgia (FM) is a syndrome that is characterized by generalized musculoskeletal pain, fatigue, unrepairable sleep, cognitive alterations, depressive and neurovegetative symptoms, whose neurobiolo...
Eligibility Criteria
Inclusion
- Literate
- Female, between 18 and 65 years old
- With the diagnosis of fibromyalgia according to the criteria of the American College of Rheumatology (2010-2016)
- Pain score equal to or greater than six on the Numerical Pain Scale (NPS 0-10) on most days of the last 3 months.
- Give informed consent to participate after the initial evaluation.
Exclusion
- Living outside the city of Porto Alegre, RS, Brazil
- Pregnancy
- Severe Mental Illness
- tDCS contraindications
- Magnetic resonance imaging (MRI) contraindications
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03841227
Start Date
August 1 2018
End Date
March 1 2020
Last Update
February 15 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90.450-120
2
Hospital de Clinicas e Porto Alegre (HCPA)
Porto Alegre, Rio Grande do Sul, Brazil, 90035-003